Evaluation of the CD123 Expression and FLT3 Gene Mutations in Patients with Acute Myeloid Leukemia
Background and Objective: Identification of cytogenetic and molecular changes plays an important role in acute myeloid leukemia (AML) patients. Thus, they are used in classification, prognosis and treatment of the disease. The CD123 expression and FLT3 gene mutations are also the variations that may...
Main Authors: | Freidoon Solhjoo, Akbar Safaie, Ahmad Monabati, Maral Mokhtari, Moeinadin Safavi |
---|---|
Format: | Article |
Language: | English |
Published: |
Iranian Society of Pathology
2018-10-01
|
Series: | Iranian Journal of Pathology |
Subjects: | |
Online Access: | https://ijp.iranpath.org/article_32424_ce2ae7f38cdf4ce4158722ef3db51787.pdf |
Similar Items
-
Targeting FLT3 Mutations in Acute Myeloid Leukemia
by: Riad El Fakih, et al.
Published: (2018-01-01) -
Clinical Efficacies of FLT3 Inhibitors in Patients with Acute Myeloid Leukemia
by: Moo-Kon Song, et al.
Published: (2022-10-01) -
FLT3 inhibitors in acute myeloid leukemia
by: Mei Wu, et al.
Published: (2018-12-01) -
Mechanisms Underlying Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia
by: Motoki Eguchi, et al.
Published: (2020-07-01) -
Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia
by: Bai‐Liang He, et al.
Published: (2020-04-01)